CA Stock MarketDetailed Quotes
ENBI Entheon Biomedical Corp
- 0.090
- 0.0000.00%
15min DelayMarket Closed Jul 31 14:51 ET
797.30KMarket Cap-1500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.090Pre Close0.00Turnover0.25052wk High0.00%Turnover Ratio8.86MShares0.05052wk Low-0.06EPS TTM689.30KFloat Cap13.500Historical HighLossP/E (Static)7.66MShs Float0.050Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM2.73P/B1Lot Size--Div YieldTTM
Entheon Biomedical Corp Key Stats
Quarterly+Annual
YOY
| (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 31.97%250.32K | 0 | 0 | 130.32K | 120K | 189.68K | 1,731.32%120K | 1,081.17%69.68K |
| Operating revenue | --0 | --0 | 31.97%250.32K | --0 | --0 | --130.32K | --120K | --189.68K | 1,731.32%120K | 1,081.17%69.68K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -36.55%102.07K | -66.03%77.93K | -85.11%564.32K | -78.48%76.03K | -86.87%96.45K | -86.35%160.87K | -84.94%229.4K | -53.86%3.79M | -70.75%353.31K | -57.92%734.69K |
| Selling and administrative expenses | -36.55%102.07K | -66.03%77.93K | -78.20%564.32K | -78.28%76.03K | -85.68%96.45K | -78.28%160.87K | -72.15%229.4K | -63.01%2.59M | -78.39%349.99K | -45.67%673.52K |
| -Selling and marketing expense | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -97.25%60.6K | -99.83%629 | -97.24%6.54K |
| -General and administrative expense | -36.55%102.07K | -66.03%77.93K | -77.68%564.32K | -78.24%76.03K | -85.54%96.45K | -78.23%160.87K | -70.29%229.4K | -47.31%2.53M | -71.83%349.36K | -33.48%666.98K |
| Research and development costs | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -1.08%1.2M | -94.08%2.39K | -80.62%61K |
| Depreciation amortization depletion | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -45.41%2.1K | 100.20%924 | -99.91%165 |
| -Depreciation and amortization | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -45.41%2.1K | 100.20%924 | -99.91%165 |
| Operating profit | -234.14%-102.07K | 28.77%-77.93K | 91.28%-313.99K | 67.41%-76.03K | 85.50%-96.45K | 97.41%-30.55K | 92.82%-109.4K | 56.17%-3.6M | 80.74%-233.31K | 61.86%-665.01K |
| Net non-operating interest income (expenses) | 7.51K | 3.07K | 868.65%7.32K | 0 | 0 | -92.74%756 | ||||
| Non-operating interest income | --7.51K | --3.07K | 868.65%7.32K | ---- | ---- | --0 | --0 | -92.74%756 | ---- | ---- |
| Other net income (expenses) | -99.64%5.49K | 46.81%-6.04K | -99.88%1.6K | -102.38%-5.45K | 168.46%13.81K | 648.68%1.54M | -104.99%-11.35K | 6,181.48%1.34M | ||
| Gain on sale of security | ---- | ---- | 108.67%4.2K | -67.61%13.61K | 88.68%-3.97K | 84.53%-5.45K | 168.46%13.81K | -123.35%-48.41K | -84.86%42.02K | -29.84%-35.07K |
| Special income (charges) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---1.71K | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---1.71K | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | -99.92%1.29K | 61.96%-19.65K | -99.60%5.57K | ---- | ---- | 84,719.29%1.59M | -2.86%-51.66K | 2,744.66%1.38M |
| Income before tax | -162.73%-94.56K | 21.69%-74.86K | 85.45%-300K | 69.84%-73.56K | -114.05%-94.86K | 96.21%-35.99K | 93.81%-95.59K | 74.23%-2.06M | 75.16%-243.9K | 139.27%675.15K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -162.73%-94.56K | 21.69%-74.86K | 96.48%-300K | 98.74%-73.56K | -120.70%-94.86K | 97.17%-35.99K | 94.88%-95.59K | 4.12%-8.52M | -212.40%-5.84M | 126.65%458.19K |
| Net income continuous operations | -162.73%-94.56K | 21.69%-74.86K | 85.45%-300K | 69.84%-73.56K | -114.05%-94.86K | 96.21%-35.99K | 93.81%-95.59K | 74.23%-2.06M | 75.16%-243.9K | 139.27%675.15K |
| Net income discontinuous operations | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -627.50%-6.46M | ---5.6M | ---216.95K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -162.73%-94.56K | 21.69%-74.86K | 96.48%-300K | 98.74%-73.56K | -120.70%-94.86K | 97.17%-35.99K | 94.88%-95.59K | 4.12%-8.52M | -212.40%-5.84M | 126.65%458.19K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -162.73%-94.56K | 21.69%-74.86K | 96.48%-300K | 98.74%-73.56K | -120.70%-94.86K | 97.17%-35.99K | 94.88%-95.59K | 4.12%-8.52M | -212.40%-5.84M | 126.65%458.19K |
| Diluted earnings per share | 0.00%-0.01 | 50.00%-0.01 | 96.53%-0.05 | 98.98%-0.0117 | -116.05%-0.0161 | 96.67%-0.01 | 93.33%-0.02 | 10.00%-1.44 | -280.00%-1.14 | 133.33%0.1 |
| Basic earnings per share | 0.00%-0.01 | 50.00%-0.01 | 96.53%-0.05 | 98.91%-0.0125 | -116.05%-0.0161 | 96.67%-0.01 | 93.33%-0.02 | 10.00%-1.44 | -280.00%-1.14 | 133.33%0.1 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg